Leishmania infantum arginase: biochemical characterization and inhibition by naturally occurring phenolic substances

References

• Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, et al. Leishmaniasis: a review. F1000Res 2017;6:750.
   PubMedGoogle Scholar
• Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012;7:e35671.
   PubMed Web of Science ®Google Scholar
• Das A, Karthick M, Dwivedi S, et al. Epidemiologic correlates of mortality among symptomatic visceral leishmaniasis cases: findings from situation assessment in high endemic foci in India. PLoS Neglect Trop Dis 2016;10:e0005150.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Global Health Observatory (GHO) data. Leishmaniasis: Situation and trends. Available from https://www.who.int/gho/neglected_diseases/leishmaniasis/en/. [last accessed 23 Feb 2019].
   Google Scholar
• Uliana SRB, Trinconi CT, Coelho AC. Chemotherapy of leishmaniasis: present challenges. Parasitology 2018;145:464–80.
   PubMed Web of Science ®Google Scholar
• Christianson DW. Arginase: structure, mechanism, and physiological role in male and female sexual arousal. Acc Chem Res 2005;38:191–201.
   PubMed Web of Science ®Google Scholar
• Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 2009;158:638–51.
   PubMed Web of Science ®Google Scholar
• Roberts SC, Tancer MJ, Polinsky MR, et al. Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants. J Biol Chem 2004;279:23668–78.
   PubMed Web of Science ®Google Scholar
• Aoki JI, Muxel SM, Zampieri RA, et al. RNA-seq transcriptional profiling of Leishmania amazonensis reveals an arginase-dependent gene expression regulation. PLoS Negl Trop Dis 2017;11:e0006026.
   PubMed Web of Science ®Google Scholar
• Colotti G, Ilari A. Polyamine metabolism in Leishmania: from arginine to trypanothione. Amino Acids 2011;40:269–85.
   PubMed Web of Science ®Google Scholar
• Riley E, Roberts SC, Ullman B. Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I. Int J Parasitol 2011;41:545–52.
   PubMed Web of Science ®Google Scholar
• da Silva ER, Maquiaveli CC, Magalhães PP. The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase. Exp Parasitol 2012;130:183–8.
   PubMed Web of Science ®Google Scholar
• Cruz EM, da Silva ER, Maquiaveli CC, et al. Leishmanicidal activity of Cecropia pachystachya flavonoids: arginase inhibition and altered mitochondrial DNA arrangement. Phytochemistry 2013;89:71–7.
   PubMed Web of Science ®Google Scholar
• dos Reis MB, Manjolin LC, Maquiaveli CC, et al. Inhibition of Leishmania (Leishmania) amazonensis and rat arginases by green tea EGCG, (+)-catechin and (-)-epicatechin: a comparative structural analysis of enzyme-inhibitor interactions. PLoS One 2013;8:e78387.
   PubMed Web of Science ®Google Scholar
• Manjolin LC, dos Reis MB, Maquiaveli CC, et al. Dietary flavonoids fisetin, luteolin and their derived compounds inhibit arginase, a central enzyme in Leishmania (Leishmania) amazonensis infection. Food Chem 2013;141:2253–62.
   PubMed Web of Science ®Google Scholar
• de Sousa LR, Ramalho SD, Burger MC, et al. Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems. J Nat Prod 2014;77:392–6.
   PubMed Web of Science ®Google Scholar
• da Silva ER, Boechat N, Pinheiro LC, et al. Novel selective inhibitor of Leishmania (Leishmania) amazonensis arginase. Chem Biol Drug Des 2015;86:969–78.
   PubMed Web of Science ®Google Scholar
• Maquiaveli CC, Lucon-Júnior JF, Brogi S, et al. Verbascoside inhibits promastigote growth and arginase activity of Leishmania amazonensis. J Nat Prod 2016;79:1459–63.
   PubMed Web of Science ®Google Scholar
• Lacerda RBM, Freitas TR, Martins MM, et al. Isolation, leishmanicidal evaluation and molecular docking simulations of piperidine alkaloids from Senna spectabilis. Bioorg Med Chem 2018;26:5816–23.
   PubMed Web of Science ®Google Scholar
• Adinehbeigi K, Razi Jalali MH, Shahriari A, et al. In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum. Pathog Glob Health 2017;111:176–85.
   PubMed Web of Science ®Google Scholar
• Peti W, Page R. Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost. Protein Expr Purif 2007;51:1–10.
   PubMed Web of Science ®Google Scholar
• UniProt Consortium. Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 2012;40:D71–75.
   PubMed Web of Science ®Google Scholar
• Altschul SF, Madden TL, Schäffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389–402.
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000;28:235–42.
   PubMed Web of Science ®Google Scholar
• Sievers F, Wilm A, Dineen D, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 2014;7:539.
   Web of Science ®Google Scholar
• Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993;234:779–815.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, MacArthur MW, Moss DS, et al. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993;26:283–91.
   Web of Science ®Google Scholar
• D'Antonio EL, Ullman B, Roberts SC, et al. Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections. Arch Biochem Biophys 2013;535:163–76.
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91.
   PubMed Web of Science ®Google Scholar
• Rolón M, Vega C, Escario JA, et al. Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes. Parasitol Res 2006;99:103–7.
   PubMed Web of Science ®Google Scholar
• Passero LF, Bonfim-Melo A, Corbett CE, et al. Anti-leishmanial effects of purified compounds from aerial parts of Baccharis uncinella C. DC. (Asteraceae). Parasitol Res 2011;108:529–36.
   PubMed Web of Science ®Google Scholar
• Misko TP1, Schilling RJ, Salvemini D, et al. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993;214:11–6.
   PubMed Web of Science ®Google Scholar
• Katsuno K, Burrows JN, Duncan K, et al. Hit and lead criteria in drug discovery for infectious diseases of the developing world. Nat Rev Drug Discov 2015;14:751–8.
   PubMed Web of Science ®Google Scholar
• Ikemoto M, Tabata M, Miyake T, et al. Expression of human liver arginase in Escherichia coli. Purification and properties of the product. Biochem J 1990;270:697–703.
   PubMed Web of Science ®Google Scholar
• Di Costanzo L, Moulin M, Haertlein M, et al. Expression, purification, assay, and crystal structure of perdeuterated human arginase I. Arch Biochem Biophys 2007;465:82–9.
   PubMed Web of Science ®Google Scholar
• Tasdemir D, Kaiser M, Brun R, et al. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother 2006;50:1352–64.
   PubMed Web of Science ®Google Scholar
• Bordage S, Pham TN, Zedet A, et al. Investigation of mammal arginase inhibitory properties of natural ubiquitous polyphenols by using an optimized colorimetric microplate assay. Planta Med 2017;83:647–53.
   PubMed Web of Science ®Google Scholar
• Iniesta V, Gómez-Nieto LC, Corraliza I. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J Exp Med 2001;193:777–84.
   PubMed Web of Science ®Google Scholar
• Kropf P, Fuentes JM, Fähnrich E, et al. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. Faseb J 2005;19:1000–2.
   PubMed Web of Science ®Google Scholar
• Ash DE. Structure and function of arginases. J Nutr 2004;134:2760S–4S.
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337–41.
   PubMedGoogle Scholar
• Montrieux E, Perera WH, García M, et al. In vitro and in vivo activity of major constituents from Pluchea carolinensis against Leishmania amazonensis. Parasitol Res 2014;113:2925–32.
   PubMed Web of Science ®Google Scholar
• Brito SM, Coutinho HD, Talvani A, et al. Analysis of bioactivities and chemical composition of Ziziphus joazeiro Mart. using HPLC-DAD. Food Chem 2015;186:185–91.
   PubMed Web of Science ®Google Scholar
• Cunha F, Tintino SR, Figueredo F, et al. HPLC-DAD phenolic profile, cytotoxic and anti-kinetoplastidae activity of Melissa officinalis. Pharm Biol 2016;54:1664–70.
   PubMed Web of Science ®Google Scholar
• Calixto Júnior JT, de Morais SM, Gomez CV, et al. Phenolic composition and antiparasitic activity of plants from the Brazilian Northeast "Cerrado". Saudi J Biol Sci 2016;23:434–40.
   PubMed Web of Science ®Google Scholar
• Tabassum S, Ahmed M, Mirza B, et al. Appraisal of phytochemical and in vitro biological attributes of an unexplored folklore: Rhus Punjabensis Stewart. BMC Complement Altern Med 2017;17:146.
   PubMed Web of Science ®Google Scholar
• Ribeiro TG, Nascimento AM, Henriques BO, et al. Antileishmanial activity of standardized fractions of Stryphnodendron obovatum (Barbatimão) extract and constituent compounds. J Ethnopharmacol 2015;165:238–42.
   PubMed Web of Science ®Google Scholar
• Belkhelfa-Slimani R, Djerdjouri B. Caffeic acid and quercetin exert caspases-independent apoptotic effects on Leishmania major promastigotes, and reactivate the death of infected phagocytes derived from BALB/c mice. Asian Pac J Trop Biomed 2017;7:321–31.
   Web of Science ®Google Scholar
• Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 2010;53:2719–40.
   PubMed Web of Science ®Google Scholar
• Li J, Malakhova M, Mottamal M, et al. Norathyriol suppresses solar UV-induced skin cancer by targeting ERKs. Cancer Res 2012;72:260–70.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017;12:61–88.
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
  (d) Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77.
   PubMed Web of Science ®Google Scholar
  (e) Supuran CT, Vullo D, Manole G, et al. Designing of novel carbonic anhydrase inhibitors and activators. Curr Med Chem Cardiovasc Hematol Agents 2004;2:49–68.
   PubMedGoogle Scholar
• (a) Capasso C, Supuran CT. An overview of the alpha-, beta-and gamma-carbonic anhydrases from bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem 2015;30:325–32.
   PubMed Web of Science ®Google Scholar
  (b) Del Prete S, Vullo D, Fisher GM, et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum – the η-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389–96.
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72.
   PubMed Web of Science ®Google Scholar
  (d) Ozensoy Guler O, Capasso C, Supuran CT. A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization. J Enzyme Inhib Med Chem 2016;31:689–94.
   PubMed Web of Science ®Google Scholar
  (e) Pastorekova S, Casini A, Scozzafava A, et al. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg Med Chem Lett 2004;14:869–73.
   PubMed Web of Science ®Google Scholar
• (a) Briganti F, Pierattelli R, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Part 37. Novel classes of carbonic anhydrase inhibitors and their interaction with the native and cobalt-substituted enzyme: kinetic and spectroscopic investigations. Eur J Med Chem 1996;31:1001–10.
   Web of Science ®Google Scholar
  (b) Supuran CT. Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases. Expert Opin Ther Pat 2018;28:713–21.
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018;28:709–12.
   PubMed Web of Science ®Google Scholar
  (d) Winum JY, Temperini C, El Cheikh K, et al. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. J Med Chem 2006;49:7024–31.
   PubMed Web of Science ®Google Scholar
  (e) Supuran CT. Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity. Expert Opin Ther Pat 2003;13:1545–50.
   Web of Science ®Google Scholar
• (a) Clare BW, Supuran CT. Carbonic anhydrase activators. 3: Structure‐activity correlations for a series of isozyme II activators. J Pharm Sci 1994;83:768–73.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
  (c) Melis C, Meleddu R, Angeli A, et al. Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2017;32:68–73.
   PubMed Web of Science ®Google Scholar
  (d) Gul HI, Mete E, Eren SE, et al. Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides. J Enzyme Inhib Med Chem 2017;32:169–75.
   PubMed Web of Science ®Google Scholar
  (e) Gul HI, Mete E, Taslimi P, et al. Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines. J Enzyme Inhib Med Chem 2017;32:189–92.
   PubMed Web of Science ®Google Scholar
• (a) Gülçin İ, Scozzafava A, Supuran CT, et al. Rosmarinic acid inhibits some metabolic enzymes including glutathione S-transferase, lactoperoxidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase isoenzymes. J Enzyme Inhib Med Chem 2016;31:1698–702.
   PubMed Web of Science ®Google Scholar
  (b) Karioti A, Ceruso M, Carta F, et al. New natural product carbonic anhydrase inhibitors incorporating phenol moieties. Bioorg Med Chem 2015;23:7219–25.
   PubMed Web of Science ®Google Scholar
  (c) Karioti A, Carta F, Supuran CT. Phenols and polyphenols as carbonic anhydrase inhibitors. Molecules 2016;21:1649.
   PubMed Web of Science ®Google Scholar
• (a) Syrjänen L, Vermelho AB, Rodrigues Ide A, et al. Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. J Med Chem 2013;56:7372–81.
   PubMed Web of Science ®Google Scholar
  (b) Ceruso M, Carta F, Osman SM, et al. Inhibition studies of bacterial, fungal and protozoan β-class carbonic anhydrases with Schiff bases incorporating sulfonamide moieties. Bioorg Med Chem 2015;23:4181–7.
   PubMed Web of Science ®Google Scholar
• (a) Capasso C, Supuran CT. Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Expert Opin Ther Targets 2015;19:1689–704.
   PubMed Web of Science ®Google Scholar
  (b) Carta F, Osman SM, Vullo D, et al. Poly(amidoamine) dendrimers show carbonic anhydrase inhibitory activity against α-, β-, γ- and η-class enzymes. Bioorg Med Chem 2015;23:6794–8.
   PubMed Web of Science ®Google Scholar
• (a) Vermelho AB, Capaci GR, Rodrigues IA, et al. Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets. Bioorg Med Chem 2017;25:1543–55.
   PubMed Web of Science ®Google Scholar
  (b) Nocentini A, Cadoni R, Dumy P, et al. Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles. J Enzyme Inhib Med Chem 2018;33:286–9.
   PubMed Web of Science ®Google Scholar
• (a) D'Ambrosio K, Supuran CT, De Simone G. Are Carbonic Anhydrases Suitable Targets to Fight Protozoan Parasitic Diseases?. Curr Med Chem 2018;25:5266–78.
   PubMed Web of Science ®Google Scholar
  (b) Angeli A, Donald WA, Parkkila S, Supuran CT. Activation studies with amines and amino acids of the β-carbonic anhydrase from the pathogenic protozoan Leishmania donovani chagasi. Bioorg Chem 2018;78:406–10.
   PubMed Web of Science ®Google Scholar
• (a) da Silva Cardoso V, Vermelho AB, Ricci Junior E, et al. Antileishmanial activity of sulphonamide nanoemulsions targeting the β-carbonic anhydrase from Leishmania species. J Enzyme Inhib Med Chem 2018;33:850–7.
   PubMed Web of Science ®Google Scholar
  (b) Al-Tamimi AS, Etxebeste-Mitxeltorena M, Sanmartín C, et al. Discovery of new organoselenium compounds as antileishmanial agents. Bioorg Chem 2019;86:339–45.
   PubMed Web of Science ®Google Scholar
  (c) Bonardi A, Vermelho AB, da Silva Cardoso V, et al. N-nitrosulfonamides as carbonic anhydrase inhibitors: a promising chemotype for targeting chagas disease and leishmaniasis. ACS Med Chem Lett 2019;10:413–8.
   PubMed Web of Science ®Google Scholar